2015, Number 616
<< Back Next >>
Rev Med Cos Cen 2015; 72 (616)
Muestreo venoso adrenal en paciente con hiperaldosteronismo primario: Reporte de caso
Soto HE, Gutierrez JLA, Salazar SR
Language: Spanish
References: 25
Page: 597-605
PDF size: 188.19 Kb.
ABSTRACT
Primary hyperaldosteronism
is the most frequent cause
of secondary arterial
hypertension. The clinical
management has evolved
significantly during the past
50 years. The adrenal vein
sampling for the differentiation
of bilateral adrenal hyperplasia
from the aldosterone tumor
or the unilateral adrenal
hyperplasia is very important
because treatment differs and
nowadays it is the method
of choice due to the 50% of
sensitivity reached by the
computerized tomography
in differentiating these
pathologies. In the present case,
the use of this procedure is used
in a 36 years old patient with
left aldosteronome that was not
well defined in the radiologic
images.
REFERENCES
Aronova A, Iii TJ, Zarnegar R. Management of hypertension in primary aldosteronism. World J Cardiol. 2014 May 26; 6(5): 227-33
Conn JW. Presidential address: 1) Painting background. 2) Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 1955; 45:3-17
Daunt N. Adrenal venous sampling hw to make it quick, easy and successful. Radiographics. 2005; 25(1): 143-158
Doppman JL, Gill Jr JR. Hyperaldosteronism: sampling the adrenal veins. Radiology. 1996; 198: 309-312
Funder et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocronol Metab. 2008; 93(9): 3266-3281
Gordon RD. Diagnostic investigations in primary aldosteronismo. Clinical medicine series on hypertension, Mc Graw- Hill International. 2001; 101-111.
Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WI, Krek AI. Clinical and pathological diversity of primary aldosteronism, including new famiial variety. Clin Exp Pharmacol Physiol. 1991; 18:283- 286
Iwaoka T, Umeda T, Sato T, Katsuragi S, Takeuchi T. High Plasma Renin Activity in Primary Aldosteronism with Malignant Hypertension. Jap Heart J 1980: 21(3): 423-28.
Jiang Y, Zhang C, Wang W, Su T, Zhou W, Jing L et al. Diagnstic valu of ACTH stimulation test in determining the subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2005 Feb 19: jc20143551
Jonsson JM, Klemm SA, Tunny TJ, Stowasser M, Gordon RD. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Comm. 1995; 207: 565- 571
Lim PO, Young WF, McDonald T. A review of the medical treatment of primary aldosteronism. J Hypertens 2001;19:353-361
Litchfield WR, Anderson BF, Weiss Rj, Lifton RP, Dluby RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension. 1998; 32: 445-450
Meyer A, Brabant G, Behrend M. Long term follow-up after adrenalectomy for primary aldosteronism. World J Surg. 2005; 29: 155-159.
Oka K, Hayashi K, Nakazato T, Suzawa T, Fujiwara K, Saruta T. Malignant Hypertension in a patient with primary aldosteronism with elevated active renin concentration. Internal Medicine. 1997; 36: 700- 704.
Piaditis G, Markou A, Papanastasiou L, Androulakis I, Kaltsas G. Progress in primary aldosteronism: A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol. 2014 Dec 23.
Raman SP, Lessne M, Kawamoto S, Chen Y, Salvatori R, Prescott JD, et al. iagnostic performance of multidetector computed tomography in distinguishing unilateral from bilateral abnormalities in primary hyperaldosteronism: comparison of multidetector computed tomography with adrenal vein sampling. J Comput Assis Tomogr. 2015 Jan 15.
Rossi GP, Aucus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014; 63:151-160
Sawka AM, Young WF, Thompson Gb, Grant CS, Fairley DR, Leibson C, et al. Primary aldosteronism: Factors involved with normalization of blood pressure after surgery. Ann Intern Med. 2001; 135: 258-261
Tanabe , Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab. 2003; 88: 2489- 2494
Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, et al. The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling. The Journal of Clinical Endocrinology & Metabolism 2005; 90:72–78
Trerotola SO, Asmar M, Yan Y, Fraker DL, Cohen DL. Failure mode analysis in adrenal vein sampling: a single-center experience. J Vasc Interv Radiol. 2014; 25(10):1611-9.
Villarroel-Ábrego H, Rivas M, Sotello D, Sorto D. Hipertensión arterial maligna e hiperaldosteronismo hiperreninémico: reporte de un caso. Rev costarric. Cardiol. 2011;13(1): 29-34
Weinberger MH, Grimm CF, Hollifield JW, Kern DC, Ganguly A, Kramer NJ, et al. Primary aldosteonism: Diagnosis, localization and treatment. Ann Intern Med. 1979; 90: 386-395
Wolley MJ, Gordon RD, Ahmed A, Stowasser M. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Endocrinol Metab. 2015 Jan 30: jc20143676
Young WF, Stanson AW, Thompson GB, Grant CS, Fairley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004; 136: 1227-1235.